Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Biofrontera AG

B8FK.DE ✓ COMPLIANT ☆ Track — members

Xetra · Healthcare · Pharmaceuticals ·

Germany Micro Cap Analyst: N/A

Last Close

$2.88

▲ +1.64%

Market Cap $17.52M · Vol 940

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$17.52M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

55.56

Momentum

Beta

-0.19

vs Market

52W High

$3.44

17.72% below

52W Low

$2.57

14.11% above

Volume

940

Avg 555

P/B

0.99

Price-to-book

ROE

N/A

Return on equity

Free Float

73.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Biofrontera AG (B8FK.DE) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does B8FK.DE pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.64%

-3.50%

-4.98%

-6.06%

YTD

+1.64%

-2.75%

-59.51%

-91.67%

Financials & Valuation

TTM · Annual

Total Revenue	$15.49M
Net Income	$-8,153,342.00
Revenue Growth (YoY)	-35.61%
Gross Margin	82.71%
Operating Margin	-10.52%
Net Profit Margin	-52.63%
ROE	N/A
ROA · ROIC	-4.86% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.12
P/B	0.99
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	6.08M

Technical Indicators

50-Day SMA	$2.84
200-Day SMA	$2.92
RSI (14)	55.56
Beta	-0.19
52-Week High	$3.44
52-Week Low	$2.57

Volume Today	940
Avg Daily Volume (30D)	555
Relative Volume	1.69x
Volatility (10D)	36.31
Volatility (30D)	29.46
Free Float	73.00%

Analyst Consensus

N/A

Current Price $2.88

Mean Target N/A

52W Low$2.57 52W High$3.44

Current

Target

$2.57 $3.44

Current Analyst target

· 0 analysts

Identifiers

ExchangeXetra

FIGIBBG001SHW0J3

ISINDE000A4BGGM7

CountryGermany

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.88% JNJ Johnson & Johnson -1.15% ABBV Abbvie Inc -1.44% NVS Novartis AG -1.90% NOVN.S Novartis AG -1.33%

Company Profile

Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itching, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The Company is also engaged in clinical development of two drug candidates: BF-derm1, a tablet with inhibitor blocking the synthesis of histamine in cells, a cause of allergic reactions; and BF1, a selective serotonin receptor to prevent migraines. The Company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MM Familien KG.